TrialBMC cancer2014

Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D).

Robyn P M Saw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.